ClearPoint Neuro CLPT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$25.54M-35.0% | -$18.91M+14.4% | -$22.09M-34.4% | -$16.44M-14.1% | ||
| $814K-16.9% | $980K+56.5% | $626K+157% | $244K+53.5% | ||
| $8.18M+18.4% | $6.91M+13.6% | $6.08M+47.3% | $4.13M+98.6% | ||
| $83K+62.7% | $51K-10.5% | $57K+3.6% | $55K-45.0% | ||
| —— | —— | $1.26M— | —— | ||
| $268K-77.8% | $1.21M-33.1% | $1.8M— | —— | ||
| $103K+114% | -$743K+40.4% | -$1.25M-128% | $4.42M+158% | ||
| —— | $3.11M— | —— | $1.59M— | ||
| —— | -$262K-332% | $113K-90.7% | $1.22M— | ||
| —— | —— | $1.7M+230% | $515K— | ||
| —— | $0— | —— | —— | ||
| -$1.01M-16.5% | -$869K-15.1% | -$755K-39.6% | -$541K— | ||
| -$23.9M-167% | -$8.95M+34.8% | -$13.72M+15.1% | -$16.17M-27.3% | ||
| $522K+89.8% | $275K-61.6% | $717K+183% | $253K— | ||
| $1.14M— | $0— | —— | —— | ||
| $615K+324% | -$275K— | —— | —— | ||
| —— | —— | $0— | $0— | ||
| $1.86M+338% | $424K+102% | $210K-37.5% | $336K— | ||
| $50.18M— | —— | —— | —— | ||
| —— | -$3.04M— | —— | —— | ||
| $908K+89.2% | $480K-35.4% | $743K+42.1% | $523K-12.4% | ||
| $69K+11.3% | $62K— | $0— | $0— | ||
| $83K+62.7% | $51K-10.5% | $57K+3.6% | $55K-45.0% | ||
| —— | $0— | —— | —— | ||
| -$1.01M-16.5% | -$869K-15.1% | -$755K-39.6% | -$541K— | ||
| $195K— | —— | -$22K-467% | $6K— | ||
| —— | -$262K-332% | $113K-90.7% | $1.22M— | ||
| $908K— | —— | —— | $0-100% | ||
| —— | —— | $1.26M— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$1.01M-16.5% | -$869K-15.1% | -$755K-39.6% | -$541K— | ||
| -$24.42M-165% | -$9.23M+36.1% | -$14.44M+12.1% | -$16.42M-27.6% | ||
| -$24.42M-165% | -$9.23M+36.1% | -$14.44M+12.1% | -$16.42M-27.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ClearPoint Neuro generate?
- ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
- What is ClearPoint Neuro's free cash flow?
- After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
- Where does ClearPoint Neuro's cash flow data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
